XML 41 R25.htm IDEA: XBRL DOCUMENT
v3.22.4

Earnings per Common Share | 12 Months Ended
--- | ---
Dec. 31, 2022
Earnings Per Share [Abstract] |
Earnings per Common Share | Earnings per Common Share: The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| For the Year Ended December 31,
| 2022 |  | 2021 |  | 2020
Basic: |  |  |  |  |
Numerator: |  |  |  |  |
Income from continuing operations | $ | 350.7 |  |  | $ | 403.1 |  |  | $ | 278.2 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (93.6) |  |  | (103.2) |  |  | (83.3) |
Less: Income from continuing operations allocated to participating securities | (1.1) |  |  | (1.1) |  |  | (0.5) |
Income from continuing operations attributable to Encompass Health common shareholders | 256.0 |  |  | 298.8 |  |  | 194.4 |
Income from discontinued operations, net of tax | 15.2 |  |  | 114.1 |  |  | 90.6 |
Less: Net income attributable to noncontrolling interests included in discontinued operations | (1.3) |  |  | (1.8) |  |  | (1.3) |
Less: Income from discontinued operations allocated to participating securities | (0.1) |  |  | (0.7) |  |  | (0.5) |
Income from discontinued operations attributable to Encompass Health common shareholders | 13.8 |  |  | 111.6 |  |  | 88.8 |
Net income attributable to Encompass Health common shareholders | $ | 269.8 |  |  | $ | 410.4 |  |  | $ | 283.2 |
Denominator: |  |  |  |  |
Basic weighted average common shares outstanding | 99.2 |  |  | 99.0 |  |  | 98.6 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |
Continuing operations | $ | 2.58 |  |  | $ | 3.02 |  |  | $ | 1.97 |
Discontinued operations | 0.14 |  |  | 1.13 |  |  | 0.90 |
Net income | $ | 2.72 |  |  | $ | 4.15 |  |  | $ | 2.87 |
Diluted: |  |  |  |  |
Numerator: |  |  |  |  |
Income from continuing operations | $ | 350.7 |  |  | $ | 403.1 |  |  | $ | 278.2 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (93.6) |  |  | (103.2) |  |  | (83.3) |
Income from continuing operations attributable to Encompass Health common shareholders | 257.1 |  |  | 299.9 |  |  | 194.9 |
Income from discontinued operations, net of tax | 15.2 |  |  | 114.1 |  |  | 90.6 |
Less: Net income attributable to noncontrolling interests included in discontinued operations | (1.3) |  |  | (1.8) |  |  | (1.3) |
Income from discontinued operations attributable to Encompass Health common shareholders | 13.9 |  |  | 112.3 |  |  | 89.3 |
Net income attributable to Encompass Health common shareholders | $ | 271.0 |  |  | $ | 412.2 |  |  | $ | 284.2 |
Denominator: |  |  |  |  |
Diluted weighted average common shares outstanding | 100.4 |  |  | 100.2 |  |  | 99.8 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |
Continuing operations | $ | 2.56 |  |  | $ | 2.99 |  |  | $ | 1.96 |
Discontinued operations | 0.14 |  |  | 1.12 |  |  | 0.89 |
Net income | $ | 2.70 |  |  | $ | 4.11 |  |  | $ | 2.85 |
The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| For the Year Ended December 31,
| 2022 |  | 2021 |  | 2020
Basic weighted average common shares outstanding | 99.2 |  |  | 99.0 |  |  | 98.6 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.2 |  |  | 1.2 |  |  | 1.2 |
Diluted weighted average common shares outstanding | 100.4 |  |  | 100.2 |  |  | 99.8 |
Options to purchase approximately 0.4 million, 0.2 million, and 0.2 million shares of common stock were outstanding during December 31, 2022, 2021, and 2020, respectively, but were not included in the computation of diluted weighted-average shares because to do so would have been antidilutive. In February 2014, our board of directors approved an increase in our common stock repurchase authorization from $200 million to $250 million. The repurchase authorization does not require the repurchase of a specific number of shares, has an indefinite term, and is subject to termination at any time by our board of directors. On July 24, 2018, the Company's board approved resetting the aggregate common stock repurchase authorization to $250 million. There were no repurchases of our common stock during 2022 or 2021. During 2020, we repurchased 0.1 million shares of our common stock in the open market for $6.1 million. In July 2019, our board of directors approved an increase in our quarterly dividend and declared a cash dividend of $0.28 per share. The cash dividend of $0.28 per common share was declared and paid in each quarter through July 2022. In July 2022, our board of directors revised our quarterly dividend in response to the Spin Off and declared a cash dividend of $0.15 per share that was paid in October 2022. Also in October 2022, our board of directors declared cash dividends of $0.15 per share that was paid in January 2023. Future dividend payments are subject to declaration by our board of directors.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration